KCT0000802招募中未知
An open-label, randomized, single-dose, 2way crossover study to compare the pharmacokinetics of Traclear 62.5 mg 2 tablets and HGP1206 125 mg 1 tablet in healthy male volunteers
Hanmi Pharm0 个研究点目标入组 28 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 55(Year)（—）
- 性别
- Male
入选标准
- •1.Healthy male volunteers, age 20 to 55 years.
- •2.The result of Body Mass Index(BMI) is not less than 19 kg/m2 , no more than 27 kg/m2
排除标准
- •1. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
- •2. Hypersensitive reactions to traclear, or other drugs (aspirin, antibiotics ect.) or, history of clinically significant hypersensitive reactions
研究者
相似试验
已完成
不适用
A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Bioequivalence of the co-administration of telmisartan and rosuvastatin and YH16410KCT0001231Yuhan180
进行中（未招募）
不适用
A randomized, open-label, single-dose, 2-way cross-over study to compare the safety and the pharmacokinetic characteristics of CPBI402 in healthy male volunteersDiseases of The genitoruinary systemKCT0001767Corepharmbio34
进行中（未招募）
不适用
A single-dose, open-label, randomized, 2-way crossover, clinical pharmacology study of four inhalations of CHF 1535 100/6 NEXT DPI® (fixed combination of beclomethasone dipropionate 100µg plus formoterol fumarate 6 µg) versus the same dose of CHF 1535 100/6 pMDI both administered with charcoal block. - (duplicate) Clinical pharmacology study of CHF1535 NEXT DPI versus CHF1535 pMDIMedDRA version: 13.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2010-024384-40-GBChiesi Farmaceutici S.p.A.24
已完成
不适用
A randomized, open-label, single dose, 2-way crossover study to evaluate the pharmacokinetic characteristics of EL-1401 in comparison to the co-administration of nebivolol and rosuvastatin in healthy volunteersDiseases of the circulatory systemKCT0002283Elyson Pharmaceutical50
已完成
不适用
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male VolunteersEndocrine, nutritional and metabolic diseaseKCT0001757Chong Kun Dang26